There are 2789 resources available
363P - Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study
Presenter: Giuseppe Lombardi
Session: ePoster Display
364P - Implementation of a comprehensive streamlined next generation sequencing (NGS) test for glioma including detection of the 1p/19q codeletion
Presenter: Sian Wood
Session: ePoster Display
365P - The analysis of FGFR-gene family alterations in glioma
Presenter: yunqian Li
Session: ePoster Display
366P - The genetic landscape of tumor predisposition syndromes in Chinese patients with glioma
Presenter: Rutong Yu
Session: ePoster Display
367P - The analysis of STAG2 variants in Chinese adult patients with glioma
Presenter: yongli bo
Session: ePoster Display
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display
369P - Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
Presenter: Angelika M. Starzer
Session: ePoster Display
370P - Prospective study of apatinib combined with whole brain radiation therapy and simultaneous integrated boost for brain metastases from lung cancer
Presenter: Guang Han
Session: ePoster Display
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Presenter: Jens Tijtgat
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display